AnalysisNews

GLMD today

$4.63+$0.87 (+23.14%)close Sep 9, 2026

Trend

DailyDowntrend (confirmed)

4 hourLeaning Bullish

1 hourDescending Triangle

15 minLeaning Bullish

5 minNo data

Daily trend turns up above $32.27

Key levels

Resistance$17.76

Resistance$9.76

Latest news & SEC filings

NewsGalmed Pharmaceuticals takes new Eocene name, Nasdaq ticker becomes EOCN

All GLMD news →

Nasdaq · Healthcare

Galmed Pharmaceuticals Ltd. (GLMD)

$4.63+0.87 (+23.14%)
WATCHLISTGrade: C+Risk: LOW
1D5D1M1Y5YMaxSign up for all timeframes
4.004.244.484.734.63Aug 6Aug 14Aug 24Sep 1
High4.63
Low3.82
Open3.91
Volume98K
Avg Vol24K
VWAP4.30
30d High4.97
30d Low3.76
30d Chg+3.39%

What Is the Price Target for GLMD?

SEPT Low Target

$0.00

SEPT Mid Target

$0.00

SEPT High Target

$0.00

Analyst Consensus

$0.00

Current: $4.66Upside: +0.0%Confidence: 20%Method: No Coverage

Is GLMD a Buy or Sell Right Now?

54
Investability Score
WATCHLIST12-18 months

Test your own strategy on GLMD

Describe your strategy in plain words, then scan, alert, backtest and paper trade it on GLMD with SEPT’s own market data.

Start Free Trial →

Is GLMD Overvalued or Undervalued?

Valuation Verdict

N/A

Methods Used

N/A

Fair Value

$N/A

5

Moat Score

NONE

0/9

Piotroski Score

N/A

Altman Z-Score

What Is Smart Money Doing with GLMD?

Insider Signal

NEUTRAL

0 buys / 0 sells (90d)

Congress Signal

NEUTRAL

0 buys / 0 sells (90d)

Institutional

N/A

Short Squeeze Risk

LOW

Signal: NEUTRAL

Track Smart Money Across 4,000+ Stocks

Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.

See Smart Money Data →

GLMD Growth Story

Revenue YoY

N/A%

3yr Revenue CAGR

N/A%

EPS Growth YoY

N/A

FCF Growth YoY

N/A%

Revenue Trend

UNKNOWN

Dark Pool Trades for GLMD

PREVIEW

Recent off-exchange (dark pool) prints for GLMD: size, dollar value and side. One of the data views on SEPT, alongside its own pressure bars, swings, volume spike levels and key levels.

TimePriceSizeValueSide
20:44:01$4.502,335$$11KSELL
20:08:00$4.701,900$$9KBUY
19:59:57$4.581,158$$5KMIDPOINT
19:21:45$4.421,809$$8KSELL
16:02:01$4.151,624$$7KSELL

5 dark pool trades shown · $$39K preview volume

Real-time institutional flow, block trades, and net positioning

See all dark pool activity

Full AI Research Report

SEPT's Trading AI has generated a free, downloadable PDF research report for Galmed Pharmaceuticals Ltd. (GLMD) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.

Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (2 articles analyzed), and SEC filing intelligence...

Your strategy, tested before real money.

Describe your strategy in plain words. SEPT scans, alerts, backtests and paper trades it on its own market data. SEPT provides tools only and does not tell you what to buy or sell.

Try SEPT Free for 7 Days →

GLMD — frequently asked questions

What is GLMD stock price today?

Galmed Pharmaceuticals Ltd. (GLMD) is at $4.63, up 23.14% (+$0.87) at the Sep 9, 2026 close.

Why is GLMD stock moving today?

Latest GLMD news — Sep 9, 2026: Galmed Pharmaceuticals takes new Eocene name, Nasdaq ticker becomes EOCN

Did GLMD beat earnings?

GLMD last reported on Sep 2, 2026: EPS -$2.86 vs -$3.12 expected — a beat of 8.3%.

What are GLMD support and resistance levels?

Resistance: $9.76, $17.76, $26.62.

What are insiders doing with GLMD?

Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.

What is the latest news on GLMD?

Sep 9, 2026: Galmed Pharmaceuticals takes new Eocene name, Nasdaq ticker becomes EOCN